KWM
TMO icon

Kolinsky Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Kolinsky Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$816K Sell
1,745
-148
-8% -$81.4K 0.5% 32
2024
Q3 		$1.03M Buy
1,893
+45
+2% +$26.6K 0.67% 20
2024
Q2 		$883K Buy
1,848
+654
+55% +$375K 0.63% 27
2024
Q1 		$694K Buy
1,194
+164
+16% +$92K 0.53% 35
2023
Q4 		$547K Sell
1,030
-16
-2% -$7.75K 0.48% 43
2023
Q3 		$529K Buy
1,046
+74
+8% +$39.4K 0.53% 38
2023
Q2 		$500K Buy
972
+64
+7% +$34.5K 0.47% 46
2023
Q1 		$523K Sell
908
-6
-0.7% -$3.38K 0.56% 33
2022
Q4 		$503K Buy
914
+19
+2% +$10.1K 0.57% 34
2022
Q3 		$454K Sell
895
-2
-0.2% -$1.12K 0.57% 34
2022
Q2 		$487K Sell
897
-27
-3% -$14.9K 0.58% 32
2022
Q1 		$546K Sell
924
-31
-3% -$17.8K 0.54% 33
2021
Q4 		$637K Buy
+955
New +$596K 0.59% 28

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Kolinsky Wealth Management's TMO Position: Q4 2024 in Review

Kolinsky Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 7.8% in Q4 2024, selling an estimated $81.4K and leaving 1,745 shares worth $816K. The position accounts for 0.5% of the portfolio, ranked #32.

Kolinsky Wealth Management first reported a position in TMO in Q4 2021 and has held it in 13 quarters since. The position peaked at $1.03M in Q3 2024. 2,623 funds tracked by Wall St. Rank hold TMO as of Q4 2024.

  • Kolinsky Wealth Management held 1,745 shares of Thermo Fisher Scientific worth $816K as of Q4 2024.
  • Kolinsky Wealth Management sold 148 Thermo Fisher Scientific shares in Q4 2024, an estimated $81.4K.
  • Thermo Fisher Scientific made up 0.5% of Kolinsky Wealth Management's portfolio in Q4 2024, its #32 holding.
  • Kolinsky Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 13 quarters since.
  • Kolinsky Wealth Management's Thermo Fisher Scientific position peaked at $1.03M in Q3 2024.
  • 2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2024.

Based on Kolinsky Wealth Management's 13F filing for Q4 2024, filed 18 Feb 2025.